Humana Inc. (NYSE:HUM) Holdings Boosted by Paralel Advisors LLC

Paralel Advisors LLC lifted its stake in shares of Humana Inc. (NYSE:HUM) by 10.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 7,240 shares of the insurance provider’s stock after acquiring an additional 656 shares during the quarter. Paralel Advisors LLC’s holdings in Humana were worth $1,837,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Pinnacle Wealth Management Advisory Group LLC lifted its stake in shares of Humana by 3.6% in the 4th quarter. Pinnacle Wealth Management Advisory Group LLC now owns 1,070 shares of the insurance provider’s stock valued at $272,000 after purchasing an additional 37 shares during the last quarter. Atlas Brown Inc. lifted its holdings in Humana by 0.6% in the fourth quarter. Atlas Brown Inc. now owns 6,352 shares of the insurance provider’s stock valued at $1,611,000 after buying an additional 38 shares during the period. Mather Group LLC. increased its stake in Humana by 21.0% in the fourth quarter. Mather Group LLC. now owns 236 shares of the insurance provider’s stock valued at $60,000 after purchasing an additional 41 shares in the last quarter. Capital Advisors Ltd. LLC increased its position in shares of Humana by 26.1% during the fourth quarter. Capital Advisors Ltd. LLC now owns 208 shares of the insurance provider’s stock worth $53,000 after acquiring an additional 43 shares in the last quarter. Finally, Retirement Planning Co of New England Inc. boosted its holdings in Humana by 4.7% during the fourth quarter. Retirement Planning Co of New England Inc. now owns 966 shares of the insurance provider’s stock worth $245,000 after purchasing an additional 43 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Wall Street Analysts Forecast Growth

HUM has been the topic of a number of recent research reports. Mizuho raised their price target on shares of Humana from $305.00 to $316.00 and gave the stock an “outperform” rating in a research report on Wednesday. Morgan Stanley decreased their price target on shares of Humana from $301.00 to $285.00 and set an “equal weight” rating for the company in a research note on Wednesday, February 12th. Barclays boosted their price target on shares of Humana from $255.00 to $270.00 and gave the stock an “equal weight” rating in a report on Thursday, February 13th. Cantor Fitzgerald reissued a “neutral” rating and issued a $290.00 price target on shares of Humana in a report on Wednesday, February 12th. Finally, Piper Sandler increased their price target on shares of Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a research report on Wednesday, January 15th. Seventeen equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $284.25.

Humana Stock Up 0.6 %

HUM stock traded up $1.62 during trading on Thursday, reaching $287.15. 94,950 shares of the company traded hands, compared to its average volume of 1,737,660. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. The company has a market capitalization of $34.66 billion, a price-to-earnings ratio of 28.86, a price-to-earnings-growth ratio of 2.05 and a beta of 0.62. The business has a 50 day simple moving average of $265.60 and a 200 day simple moving average of $270.92. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $406.46.

Humana (NYSE:HUM) last announced its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. On average, equities research analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be issued a $0.885 dividend. The ex-dividend date of this dividend is Friday, March 28th. This represents a $3.54 annualized dividend and a dividend yield of 1.23%. Humana’s dividend payout ratio is presently 35.58%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.